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ABSTRACT 
    Human induced pluripotent stem cells (hiPSCs) have the potential to generate patient-
specific cells to treat many incurable diseases by cell replacement therapy. However, so far the 
culture of hiPSCs depends greatly on feeder cells or Matrigel which has safety issues. Thus, 
chemically defined substrates that could provide niches necessary for cell attachment and 
proliferation are preferred for clinical application of hiPSCs. Recently, Corning Life Sciences 
has developed synthetic peptide-functionalized cell culture surface, referred to as Corning® 
Synthemax™ that support self-renewal and differentiation of human embryonic stem cell 
(hESC). In this work, we have collaborated with Corning to investigate the attachment, 
proliferation, and differentiation of hiPSCs on the Synthemax substrate. We demonstrated that 
iPS cells retained stable proliferation and pluripotency marker protein expression after growing 
on the Synthemax substrate for ten consecutive passages. Further examination reveals that 
integrins αVβ5 mediates attachment to the substrate. Moreover, we observed hiPSCs colonies 
were more compact on the Synthemax surface. This may be due to less activation of β-catenin-
mediated Wnt signaling pathway in cells on the synthetic peptide surface. In hiPSCs grown on 
the Synthemax Surface, we also found denser actin filaments in the cell-cell interface and down-
regulation of vinculin and up-regulation of zyxin, indicating the reorganization of cytoskeleton 
structure inside cells in response to cell-matrix interaction.  
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CHAPTER1 INTRODUCTION 
 
Human embryonic stem (hES) cells are valuable for many clinical applications. The emergence 
of induced pluripotent stem cell (iPSC) technology raises hope of generating patient-specific 
cells for cell replacement therapy. The clinical application of these cells necessitates the 
development of new technologies that enable maintaining and differentiating these cells under 
chemically-defined or xeno-free conditions due to safety concerns over the use of animal-derived 
products in current human pluripotent stem cell (HPSC) maintenance and differentiation systems. 
This project focuses on developing xeno-free substrates for long-term HPSC maintenance and 
directed differentiation for clinical applications. 
 
1.1 Stem cells 
1.1.1 Human embryonic stem 
Human embryonic stem cells (hESCs) are derived from inner cell mass of blastocysts (1, 2, 3, 4) 
and have the potential to be undifferentiated into any type of cells in the body as listed in Table 
1. (5). They are able to self-renew indefinitely and the generation of specialized cell type 
provides the potential for cell replacement therapies to replace damaged and diseased organ or 
tissue in the patient’s body. Therefore, hES cell represents a promising cell source for disease 
treatment using cell-based therapy, such as Alzheimer's disease (AD), Parkinson’s disease (PD), 
and diabetes. In addition, hES cells can be used for drug discovery, toxicity study, gene therapy, 
and basic research of development biology. Nevertheless, use of hES cells for research is 
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ethically controversial since the embryonic stem cells come from surplus of embryos during in 
vitro fertilization (IVF). Immune rejection to the recipients is another major concern using hES 
cells as a therapeutic source during transplantation.  
 
Table 1 Examples for human embryonic stem cell–derived cell types (5) 
Layers 
 
Tissues and cells 
 
Ectoderm 
 
neural precursors, dopamine neurons, motor neurons, retinal cells, 
keratinocytes melanocytes 
 
Mesoderm 
 
fat, cartilage, skeletal muscle, bone, blood cells, cardiomyocytes 
Endoderm 
 
prostate cells, hepatocytes, lung epithelium 
 
1.1.2 Induced pluripotent stem cells 
In 1996, a groundbreaking technology so called “Induced pluripotent stem cells technology” or 
“iPS cell technology” was first publicized by Shinya Yamanaka group at Kyoto University in 
Japan. This technology allows reprogramming any adult somatic cells into embryonic stem cells-
like cells. The reprogrammed cells possess pluripotency as hES cells do (6, 7, 8, 9). In the iPS 
cell technology, four transcription factors, Oct3/4, Sox2, c-Myc, and Klf4 were cloned into 
retroviral vectors and then traduced into mouse fibroblast cells. The transduced cells showed 
similar properties of hES cells in morphology, global gene-expression, epigenetic state, 
teratomas formation, and differentiation ability (7). With the same procedures, Yamanaka and 
his colleagues produced human iPS cells from human fibroblast cells in 2007 (8). Meantime, 
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generation of human iPS cells reprogramming was published in Science from Thomson’s group 
in the United State in 2007 (9).  
 
Clearly, the advantages of iPS cells over hES cells are 1) There are no ethical issues since there 
is no needed to isolate pluripotent stem cells from an embryo. 2) There is no concern about 
immune rejection to the recipients in cell- or organ- transplantation since the cells can be 
generated directly from the patient. iPS cells can be generated by biopsy from the patient and 
then reprogrammed them into pluripotent cells, followed by induced differentiation into a cell 
type for realization of patient-specific cell-based therapies. Thus, iPS cells raise hopes for 
treating many otherwise incurable diseases through cell replacement therapies (10, 11, 12, 13). 
 
1.2 History of stem cell culture technology 
1.2.1 Feeder layer culture 
Unlike culturing many specialized cell types, culture of pluripotent stem cells including ES cells 
or iPS cells is a challenge because special niches are required for adhesion, self-renewl and 
induced differentiation of these cells. The spontaneous differentiation feature of these cells 
makes the culture and maintenance complicated. Often, to maintain pluripotent stem cells in 
undifferentiated condition is one of the major tasks in the long-term maintenance of HPSC lines. 
At the early stage of hES cell culture,  it was found that mouse embryonic fibroblasts (MEFs) as 
a feeder layer of hES cells are essential for hES cells continuously self-renew in undifferentiated 
state (3, 14). However, it is time-consuming and labor-consuming for preparing MEFs. 
Importantly, the use of animal cells has great safety concerns in clinical application due to the 
potential animal virus transmission.  
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Use human cells as a feeder layer for hES/iPS cell culture was also extensively investigated (15, 
16, 17). Human fetal muscle (FM), fetal skin (FS), and AFT epithelial cells were used to 
construct 3 feeder layers for the test of maintenance of HES3 and HES4 cells (16). The results 
show that hES cells grown in the media maintained ES features including morphology of human 
ES cells, the expression of stem cell surface markers, normal karyotypes and pluripotency (16). 
Human foreskin feeder was used as feeder layer cells to culture three hES cell lines for more 
than 42 passages and all the hES cells were maintained pluripotent features (17). Nevertheless 
there is a potential of cross contamination, since the feeder layer cells are from different origins. 
Thus, it is desired to develop feeder-free and serum-free culture system. 
 
1.2.2 Feeder free culture 
Currently, Matrigel from BD Biosciences is commonly used as a substrate for hES cells culture 
in undifferentiated state with combination of serum-free medium without using any feeder cells. 
Matrigel is a mixture of extracellular matrix proteins extracted from the Engelbreth-Holm-
Swarm (EHS) mouse tumor.  It is rich in laminin, collagen IV, heparan sulfate proteoglycans, 
entactin, nidogen and some undefined factors (18, 19, 20). Matrigel allows us to mimic the 
extracellular environment in the body. In the laboratory, Matigel has to be thawed in 4 ºC before 
coating to a cell culture plate for one hour to form a film on the surface of the cell culture plate. 
hES cells can be cultured on Matrigel in undifferentiated state for more than 130 population 
doubling (21). Cells retain normal karyotype, expression of hES cells’ markers, pluripotency and 
high telomerase activity (21). On the other hand, mTeSR medium from StemCell Technology 
was formulated for use with Matrige. This combination of the culture system allows maintenance 
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of hES and iPS cells in serum-free and feeder layer free conditions. Compared to feeder layer 
cells, preparation of Matrigel coated surface is a relatively easy and inexpensive process. 
 
However, as mentioned above Matrigel is an undefined mixture of ECM proteins produced from 
animal tumors and there are lot-to-lot variations. In addition, animal derived product may cause 
pathogenic risks. It raises significant safety concerns over Matrigel use in clinical applications. 
Hence, there is a great need to develop xeno-free, synthetic surface that capable of providing 
necessary stem cell niches to allow hES/hiPS cells expansion and differentiation in a xeno-free 
chemically defined culture system. 
 
1.3 Stem cell microenvironment 
1.3.1 Extracellular matrix (ECM) 
The extracellular matrix (ECM) in vivo contains mainly macromolecules polysaccharides, 
proteins such as different types of collagens, or proteoglycans. ECM is synthesized, secreted, and 
degraded by animal cells and distributed in the cell surface or between cells. The 
macromolecules include collagen, laminin, fibonection, vitronectin, elastin and so on. These 
substances constitute a complex network structure to support and connect the tissue structures, 
and to regulate the physiological activities of the cells. Thus, ECM is an important part in animal 
tissue. It determines the characteristics of connective tissues and plays an important role in cell 
migration, cell differentiation, cell proliferation, and apoptosis.  
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1.3.2 Integrin 
Integrins are the major proteins of cell surface receptors. They play important roles in the 
mediation of the cell and extracellular matrix adhesion and transduction information from ECM 
into the cell. Integrin is a heterodimer formed by α chain (120~185kD) and β chain (90~110kD). 
So far 18 kinds of α subunits and 9 β subunits have been found. They constitute more than 20 
kinds of different combinations of integrin. Generally, integrin proteins are transmemebrane 
proteins with a short cytoplasmic domain. There are divalent cations domains in both α subunits 
and β subunits regulating the activity of integrin. The divalent cations are Mg2+ which promotes 
binding and Ca
2+
 which inhibits the binding (23, 24). 
 
An integrin on cell surface binds to ECM macromolecules such as collagen, laminin, fibonection, 
and vitronectin. The amino acid sequence Arginine-Glycine-Aspartic acid (RGD), an 
adhesion motif, is the most common binding sites between integrin and ECM proteins (22). 
Most cells express more than one kind of integrin which is involved in several life activities. For 
example, duo to the adhesion ability, integrin can lead to platelet aggregation during the wound 
healing.  In addition, integrin is necessary for some types of cells proliferation (25, 26). If the 
interaction between integrin and ECM is blocked, the cells may fail to attach and spread. 
 
1.3.3 Stem cell niches 
Stem cell fate including self-renewal, differentiation, and death is determined by the 
microenvironment which is also called niches throughout cell-ECM or cell-cell interactions. 
Recently, stem cell niches are described as dynamic microenvironments that govern the growth 
and repair of the organism (27). For instance, a single injection of fibronectin, a glycoprotein 
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produced in the body that helps anchor cells in place, can prevent the development of chronic 
pain that often develops after a spinal cord injury (SCI) (28). A one-time injection of fibronectin 
(50 μg/mL) into the spinal dorsal column (1 μL/min each injection for a total of 5 μL) 
immediately after SCI inhibits the development of a particular type of chronic painor pain from 
pressure that would not normally cause pain-which is common in spinal cord injury patients (28). 
Bone marrow mesenchymal stem cell (MSC) not only supports the bone marrow feeder 
environment for hematopoietic stem cells, but also acts as a niche for itself. Cardiovascular 
progenitor cell (CPC) niche plays an essential role in maintenance and expansion of CPC in 
developing human and mouse hearts (29). In the ES cell differentiation and during the embryonic 
development, many phenomena are related to microenvironment, such as different gradient 
distribution of the protein such as SHH (sonic hedgehog), which can determine the 
differentiation pathways and development of the embryonic tissue to different lineages. However, 
stem cell niches and the activation of stem cells by stem cells inches are largely elusive. 
 
1.4 Wnt Pathway 
1.4.1 Overview of Wnt Pathway 
Wnt/catenin signaling pathway plays a vital role in regulating cellular proliferation, cell fate 
decision, and organ development (30, 31,32). It has been well understood that Wnt signals 
modulate -catenin expression and activate a higher level expression of integrins (33) 
 
Wnt is named after Wg (wingless) and Int (Integration) (34). Wingless gene was first found in 
Drosophila, and plays a role in embryonic development. The adult animal body forming gene Int 
was first found in vertebrates, located nearby the mouse mammary tumor virus (MMTV) 
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integration sites. Int-1 gene and the wingless gene are homological. Drosophila wingless gene 
mutation can lead to the wingless deformity, and mouse mammary tumors in MMTV replication 
and integration into the genome can lead to the synthesis of one or several Wnt genes. Different 
Wnt and Wnt ligands are derived from the common ancestor of the various organisms. Wnts 
interact with ECM molecules to elicit their functions on target cells. 
 
1.4.2 Canonical Wnt pathway 
The canonical Wnt pathway describes a series of reactions when Wnt proteins bind with Frizzled 
receptor family on the cell surface, including the activation of Dishevelled receptor family of 
proteins and the change of β-catenin levels in the nucleus. Dishevelled (DSH), one of the key 
components of the cell membrane, is related to the Wnt receptor complex. DSH is activated after 
Wnt binding to inhibit downstream protein complexes, including axin, GSK-3, and the APC 
protein. Axin/GSK-3/APC complex can promote the degradation of intracellular signaling 
molecules of β-catenin. When β-catenin destruction complex was inhibited, β-catenin in the 
cytoplasm will be stable and part of the β-catenin will transfer into the nucleus to promote the 
expression of specific genes with the TCF / LEF transcription factor family and induce Wnt 
target genes (35).  
 
1.4.3 Regulation of stem cell by canonical Wnt pathway 
Wnt pathways also play important role in maintaining stem cells in undifferentiated state, 
regulating proliferation of intestinal stem cells, skin stem cells and haematopoietic stem cells (36, 
37, 38). Activation of canonical Wnt pathway by inhibiton of GSK3β maintains pluripotency and 
self-renewal of embryonic stem cells (39). Overexpression of activated β-catenin and activation 
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of Wnt pathway leads to not only self-renewal in long-term cultures in vitro, but also 
enhancement of the reconstitution of haematopoietic lineages in vivo (38). Furthermore, 
canonical Wnt pathway determines the fate of stem cells. It is reported that the differentiation of 
neural stem cells into neuronal and glial cells were promoted by adding active Wnt3a (40). Stem 
cell can differentiate into follicular without β-catenin (41). Taken together, canonical Wnt 
pathway regulates not only the expansion of stem cells but also fate of stem cells. 
 
1.5 Synthetic peptide surface 
As discussed above, there are concerns of contamination and immunogenic response by the use 
of mouse feeder cells or Matrigel for the culture of stem cells for clinical application, because 
both of them are animal origin and have undefined factors. Thus, chemically defined substrates 
that can provide niches necessary for cell attachment and proliferation are preferred for clinical 
application of hES/iPS cell. To overcome these issues, development of xeno-free and 
chemically-defined hES/iPS cell culture system became one of the hottest topics in tissue 
engineering and regenerative medicine. In animal tissue, ECMs are an important part of niche for 
maintenance and differentiation of stem cells. Some recombinant
 
ECM proteins have already 
been investigated to support survival and self-renewal of pluripotent stem cells for several 
generations (42, 43, 44, 45). 
 
Several peptides identified using phage display libraries have been shown to support hESC 
expansion for three passages (46). Another approach that has been attempted is to synthesize 
biologically active peptides derived from Matrigel components. Since a major element of 
Matrigel is laminin, three laminin-derived active domains have also been studied for their 
10 
 
capability of supporting hESC self-renewal and proliferation. Nonetheless, these peptide-coated 
substrates can only support hESC expansions in no more than three passages (47). Microarray-
based high-throughput screening identified 16 chemically-defined acrylate monomers that can 
support hESC expansion in no more than five passages (48). Corning Life Sciences has recently 
developed synthetic peptide-functionalized cell culture surface, referred to as Corning® 
Synthemax™ Surface that support self-renewal and differentiation of hES cells (45). This 
synthetic peptide surface utilized acrylate, a widely used organic synthetic biomaterial, to form 
fast polymerization. Acrylate-containing carboxylic acid was deposited onto culture vessel 
surfaces, and then conjugated to peptides containing amines by using 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide/N-hydroxysuccinimide (EDC/NHS) to form Peptide-
acrylate surface (PAS). Five peptides derived from five proteins, including bone sialoprotein 
(BSP), vitronectin (VN), long fibronectin (sFN), short fibronectin (lFN) and laminin (LM) were 
synthesized. It was found that peptide surfaces of PAS, sFN, IFN, and LN (but not BSP-PBS and 
VN-PBS), maintain hES cells at normal morphology and undifferentiated state (45). Synthemax 
Surface was named for the VN-PAS peptide surface developed by Corning. 
 
The ability of Synthemax surface to support hES cells self-renewal and induced differentiation 
was evaluated by Corning and Geron Corporation (45). The surface can support the hES cells 
renewal (H7) for at least 12 passages with mTeSR1, Knock Out Serum-supplemented medium or 
TeSR2 without any changes in stem cells characteristics such as stable doubling time, cell 
viability, normal morphology and karyotype, and expression of pluripotency markers Oct4, 
TRA-1-60, and SSEA4. In differentiation experiments, teratomas coprising three germ layers 
(endoderm, mesoderm, and ectoderm) and embryoid bodies were formed by the differentiation of 
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H7 cultured after 8 passages on the Synthemax. In addition, Cardiomyocytes were directly 
differentiated from H7 hES cells on Synthemax surface by using a protocol in previous report 
(49). 
 
However, whether this synthetic peptide surface can support growth and differentiation of hiPSC 
remains elusive. A line of evidence suggests that hiPSCs and hESCs exhibit some differences, 
despite similar patterns in global transcriptome assessment (45). It has been found that a subset 
of 318 genes differentially expressed between these two types of (45). This small set of genes 
may represent a genetic memory of the ancestor cells from which hiPSCs were derived (45). 
Thus, it is critical to assess whether the Synthemax is suitable for hiPSC maintenance and 
differentiation. In this work, we investigated the attachment, proliferation, and differentiation of 
hiPSCs on the Synthemax Surface. The goal of this study was to determine whether hiPSCs can 
be maintained over long period of time and differentiated on the Synthemax Surface. 
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CHAPTER 2 MATERIALS AND METHODS 
 
2.1 iPS cell culture 
The human iPS cell line IMR90 was acquired from the Wicell Research Institute (Madison, WI). 
Cells were routinely maintained on growth factor reduced Matrigel (Becton Dickinson 
Biosciences, Franklin Lakes, NJ) coated dishes in a chemically defined medium mTeSR1 (Stem 
Cell Technologies, Vancouver, BC, Canada) at 37
 o
C with 5% CO2. The culture medium was 
exchanged daily. The morphology of cell colonies was examined daily and spontaneously 
differentiated colonies were removed to ensure maintenance of undifferentiated state of iPS cells. 
Two methods were applied to retain undifferentiated cells and remove differentiated cells. One 
method is called pick-to-remove. In this method, the differentiated colonies were physically 
detached from the culture dish and aspirated along with the spent media. Another method is 
called pick-to-keep, where the undifferentiated cells and colonies were physically removed and 
plated in a new plate. To characterize cell growth and differentiation on the Synthemax 
approximately 5x10
4
 cell/cm
2
 iPS cells were plated onto the Synthemax six-well plate (Corning 
Inc., Corning, NY). Cells seeded in Matrigel coated six-well plate served as a control. 
Microscopic imaging was performed daily to monitor cell attachment and proliferation. Cell 
number was counted by Trypan-blue staining in a 24 h time interval. Cell doubling time (td) was 
estimated using equation: dx/dt=µx; td=ln2/µ. 
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2.2 Immunofluorescence staining 
Immunofluorescence staining was performed using varied antibodies as primary antibodies and 
fluorescent dye conjugates as secondary antibodies to detect protein expression. In brief,  cells 
were rinsed twice in 0.5ml/well ice-cold Dulbecco's Phosphate Buffered Saline (DPBS) without 
Ca
2+
/Mg
2+
 (Mediatech, Inc. Manassas, VA) at room temperature and fixed  by freshly made 
0.5ml  of 4% paraformaldehyde (Fisher Scientific, Rockford, IL) in PBS (pH 7.4) for 15 min at 
room temperature with shaking, followed by three times washing with  ice-cold DPBS. The 
samples were incubated for 10 min with 0.5ml per well DPBS (without Ca
2+
/Mg
2+
) containing 
0.5% Triton X-100 in room temperature with shaking.  Cells were then washed with DPBS three 
times, each for 5 min with shaking. Cells were incubated with 0.5ml per well of blocking buffer 
(0.05% Tween-20, 0.1% Triton X-100, 1%BSA, 1× DPBS) for 1 hour to block nonspecific 
binding of the antibodies. After blocking, cells were incubated with primary antibodies 
(300µl/well) (Table 2) in blocking buffer overnight at 4
o
C with shaking. After washing the cells 
three times in 0.5ml/well wash buffer (0.1% BSA, 1×DPBS), each for 5 min. Cells were 
incubated in fluorophore-conjugated secondary antibodies in the dark for 1 hour at room 
temperature with shaking. Table 2 lists all the primary and secondary antibodies used in this 
study. After washing cells three times for 5 min per wash with shaking, cells were labeled with 
DAPI (diaminophenylindoleas) as well to localize cell nucleus. 4 drops of VECTASHIELD 
Mounting Medium with DAPI (Vector Laboratories, Inc. Burlingame, CA) were added to each 
well and incubate for 1 minute. The fluorescence microscopy images were captured by the 
inverted phase contrast fluorescence microscope Olympus IX71 (MVI, Avon, MA) equipped 
with a highly sensitive CCD camera (Qimaging, 32-0139-104) using Slidebook imaging analysis 
software 4.2. (Olympus Imaging America Inc., Center Valley, PA).   
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Table 2 Primary and secondary antibodies used for immunofluorescence staining 
Primary antibody company ratio Secondary 
antibody 
company ratio 
Mouse 
monoclonal anti-
human SOX17 
R&D Systems, 
Minneapolis, MN 
1:50 Goat 
anti-mouse IgG 
Sigma, St. Louis, 
MO 
1:100 
rabbit 
monoclonal anti-
human FOXA2 
Abcam, 
Cambridge, MA 
1:1000 donkey 
anti-rabbit IgG 
TRITC 
Jackson Immuno 1:50 
mouse anti-
OCT4 
EMD Millipore 
Billerica, MA 
1:100 goat anti-mouse 
Alexa Fluro 488 
IgG1 
Invitrogen, 
Carlsbad, CA 
1:200 
mouse anti-
SSEA4 
EMD Millipore 
Billerica, MA 
1:100 goat anti-mouse 
Alexa 
Fluro 488 IgG3 
Invitrogen, 
Carlsbad, CA 
1:200 
Alexa Fluor
@
488 
phalloidin 
Invitrogen 
Eugene,OR 
1:40    
rabbit anti-
vinculin 
Santa Cruz 
Biotechnology 
Inc., Santa Cruz, 
CA 
1:50  
 
anti-rabbit IgG -
FITC 
 
 
Sigma, St. Louis, 
MO 
 
 
1:150 
Rabbit anti-α-
actinin   
Sigma, St. Louis, 
MO 
1:100 
rabbit anti-zyxin Sigma, St. Louis, 1:100 
15 
 
MO 
rabbit anti-p-
FAK 
Santa Cruz 
Biotechnology 
Inc., Santa Cruz, 
CA 
1:50 
 
 
2.3 Western blotting  
2.3.1 Protein sample preparation 
Cells were cultured on Matrigel coated and Synthemax plates for 48 h.  The cells were collected 
by Typsin EDTA (Mediatech, Inc. Manassas, VA) treatment followed by centrifugation at 300×g 
for 5 min and washing with DPBS once.  The cell pellets were lysed with lysis buffer (50 mM 
Tris (pH 7.4), 150 mM NaCl, 1 mM DTT, 0.1% SDS, 1% Triton X-100, PMSF) by using a 1 ml 
syringe (Becton Dickinson, Franklin Lakes, NJ) with 20G1
1
/2 needle (Becton Dickinson, 
Franklin Lakes, NJ) up and down 20 times. Cell lysates were then centrifuged at 21,000×g for 15 
min at 4 
o
C. The supernatants were collected and protein concentration was determined using a 
Pierce BCA protein assay kit (Thermo Scientific Inc., Rockford, IL). Cytoplasmic and nuclear 
proteins were extracted using a kit from Thermo Scientific. The protein samples were stored at -
80
o
C for further experiments.  
 
2.3.2 SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
Certain amount of cellular protein samples were mixed with 2×Laemmli loading buffer (Bio-Rad 
Laboratories, Inc., Hercules, CA) containing 5% of β-mercaptoethanol and heated at 98°C for 5 
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minutes. After heat treatment, the samples were centrifuged at 21,000 ×g for 5 min. The samples 
were loaded into wells of a 4-20% Mini-Protein
®
 Precast gel  (Bio-Rad Laboratories, Inc., 
Hercules, CA)  and electrophoresis was run in the Tris/Glycine/SDS running buffer  (Bio-Rad 
Laboratories)  at 200 V for 30 min. Magic Mark
TM
  XP Western Standard (Invitrogen, Carlsbad, 
CA) was used as a protein standard.  
 
2.3.3 Immuno blotting and detection 
PVDF nitrocellulose membrane was prewetted in methonal for 1 min and then soaked in a 
transfer buffer (24.8 mM Tris, 192 mM Glycine, and 20% v/v methanol). After SDS-PAGE 
electrophoresis, the gel was carefully removed from the cassette and embedded into a transfer 
cassette in the following order:  a sponge, filter paper, 0.45 µm nitrocellulose membrane (Bio-
Rad Laboratories), the gel, filter paper, and a sponge. Protein transferring was performed in the 
Tetra Cell (Bio-Rad Laboratories). The Tetra Cell was filled with a transfer buffer with an ice 
box to keep membrane transferring at low temperature. Transfer was conducted at 100 V for 1 
hour. After washing the membrane with Tween-PBS (1x PBS, 0.05 % Tween-20) buffer twice for 
5 minutes with shaking, the membrane was incubated in a blocking buffer (1x PBS, 0.05 % 
Tween-20, 5% non-fat milk) for 1 hour with shaking at room temperature.  The membrane was 
incubated with primary antibodies (Table 3) in blocking buffer for 1 hour or overnight at 4
o
C 
with shaking. After three times washing with Tween-PBS buffer, the membrane was incubated 
with corresponding secondary antibodies (Table 3) conjugated to horseradish peroxidase for one 
hour with shaking, followed by wash three times. Lastly, the membrane was incubated for 1 
minute in a Super Signal West Substrate Working Solution (Thermo Scientific Inc., Rockford, 
17 
 
IL). Protein expression was detected using a Molecular Imager ChemiDoc XRS System (Bio-
Rad Laboratories) and PDQuest Analysis software from Bio-Rad Laboratories, Inc.  
 
Table 3 Primary and secondary antibodies used for Western blotting analysis 
Primary antibody company ratio Secondary 
antibody 
company ratio 
rabbit anti-
vinculin 
Santa Cruz 
Biotechnology 
Inc., Santa Cruz, 
CA 
1:200  
 
anti-rabbit IgG 
HRP 
    
 
Sigma, St. Louis, 
MO 
 
 
1:1000 
Rabbit anti-α-
actinin   
Sigma, St. Louis, 
MO 
1:1000 
rabbit anti-zyxin Sigma, St. Louis, 
MO 
1:1000 
Rabbit anti-
human 
β-catenin 
Sigma, St. Louis, 
MO 
1:2000 
 
2.4 Integrin blocking assay 
In order to examine the involvement of intgrins in cell attachment in the synthetic peptide 
surface (50), IMR90 cells were detached by dispase treatment followed by gentle scraping. 
Collected cells were washed by CMRL-BSA medium containing L-glutamine, pyruvate, 0.35% 
BSA, CMRL 1066 (Mediatech, Inc. Manassas, VA). Approximately 70,000 cells were incubated 
in the presence of or absence of anti- human integrin antibodies in 1 ml CMRL-BSA medium. A 
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total of six samples were carried out. They were control (without antibody), anti-α5, anti-β1, anti-
α6, anti-αVβ5, and anti- all the 4 antibodies (total). 10 µg of 1mg/ml integrin antibodies (EMD 
Millipore Billerica, MA) were added to each sample. For the total of 4 antibodies mixture, 10 µg 
of each type of anti-integrin antibodies were used. The cells were then seeded to the wells of 
Synthemax plate and cultured for 1 h at 37
o
C in cell culture CO2 incubator. Cells were also 
seeded to Matrigel-coated plate for comparison. After incubation, cells were washed 3 times by 
CMRL-BSA medium, followed by fixation using 100% ethanol (0.5 ml/well) for 5 minutes. 
Cells were then stained by 0.4% crystal violet in methanol (0.5 ml/well) for 5 minutes and 
washed by deionized H2O at least 5 times. At least 7 regions were randomly selected and colony 
numbers were counted under a microscopy using the 10x objective lens. Images were taken by 
an inverted phase contrast fluorescence microscope Olympus IX71 equipped with a highly 
sensitive CCD camera and Slidebook imaging analysis software 4.2 (Olympus Imaging America 
Inc., Center Valley, PA). The experiments were repeated at least three times independently.  
 
2.5 Definitive endoderm differentiation from human iPS cell 
Differentiation of IMR90 cells into definitive endoderm (DE) was conducted as described in our 
previous work (51). Briefly, cells were seeded onto Synthemax plate and cultured in the mTeSR1 
medium. Cells were fed with differentiation medium when cells reached 40-50% confluence. DE 
medium contains of RPMI1640, nonessential amino acids, sodium pyruvate, B27 (Invitrogen), 
1mM sodium-butyrate (Sigma), and 4 nM activin A. After 24 hour of differentiation, sodium 
butyrate concentration was reduced to 0.5mM in the differentiation medium. The medium was 
exchanged every other day until day 7 post differentiation. 
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2.6 Quantitative real time–polymerase chain reaction (qRT-PCR) analysis 
To detect the expression of two DE marker genes, SOX17 and FOXA2, in DE tissue 
differentiated from iPS cells, total RNA were extracted from the cells using a RNA extraction kit 
RNeasy Plus Mini from QIAGEN (Valencia, CA). TaqMan qRT-PCR was performed using 
QuantiTecT Muptiplex RT-PCR NR Kit (Qiagen) according to the manufacturer’s protocol. The 
cyclophilin (Applied Biosystems, University Park, IL), a human housekeeping gene, was served 
as endogenous control for normalization. RNA from adult human pancreata (Stratagene, La 
Jolla, CA) was used for comparison and normalization to detect relative mRNA expression level 
of DE cells.  No reverse transcription control, and no template control samples were also 
performed to ensure the absence of genomic DNA amplification in the qRT-PCR assay and no 
false positive signal produced in the detection and analysis. The primer-probe pairs (52)
 
were 
used as below: 
Sox17 forward (5’ to 3’): CAGCGAATCCAGACCTGCAGACCTGCA, 
Sox17 reverse (5’ to 3’): GTCAGCGCCTTCCACGACT,  
Sox17-probe (5’FAM to 3’-Tam): ACGCCGAGGGCTACTCCTCC 
 
Foxa2 forward (5’ to 3’): CCGACTGGAGCAGCTACTATG,  
Foxa2 reverse (5’ to 3’): TACGTGTTCATGCCGTTCAT, 
Foxa2- probe (5’FAM to 3’-Tam): CAGAGCCCTCGGCACTGCC 
 
2.7 Statistical analyses 
Data were presented as mean ± standard deviation. The statistical analysis was performed based 
on the Student’s t-test using a one-tailed algorithm. The significance was determined at p 0.05.   
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CHAPTER 3 RESULTS AND DISCUSSION 
 
3.1 Characterization of iPS cells attachment and proliferation on synthetic peptide surface 
To evaluate the attachment and proliferation of iPS cells on synthetic peptide surface, iPS cells 
IMR90 were seeded on the Synthemax plate. Cells grown on a Matrigel coated conventional 
tissue culture plate served as a control for comparison. We observed that cell attachment time is 
different between the two types of surfaces. The cells on Synthemax surface need more time to 
attach to the surface. After culture for 2 days, colony morphology of cells on synthetic peptide 
surface were more round compared with that on Matrigel coated surface (Fig.1). Also the 
colonies grown on Synthemax plate are smaller throughout the culture.  
 
 
 
 
 
 
 
                                                      MG                                                         SM 
       
 
Figure1. IMR90 cell colony grown on Matrigel (MG) and Synthemax surface (SM). 
 
Fig.2 shows a typical time course of iPS cell proliferation on both Matrigel- and synthetic 
peptide-coated surfaces. In these experiments, approximately 5x10
4
 cell/cm
2
 IMR90 cells were 
seeded into a well of Synthemax surface modified six-well plate. The same number of cells were 
used to seed to a Matrigel coated six-well plate. As shown in Fig. 2, the kinetics of cell growth 
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indicated that cells grown on Synthemax are equivalent to that on Matrigel. Equation 1 was used 
to calculate the doubling time:  
                                                        X=X
0
e
µt
    (1) 
Where X is the amount of cells; X
0
 is the amount of cells at time 0; µ is the specific growth rate; 
t is the culture time. 
                                               Ln(X) =Ln(X
0
) +µt     (2) 
When X= 2X
0
,  
So,    doubling time= Ln2/µ                (3)                            
By counting cell number X and X0, µ can be obtained from the slope of the linear equation. After 
substituting µ to the equation, doubling times can be calculated by Equation 3. Accordingly, the 
doubling times of cells on Synthemax and Matrigel coated plate are 44.05±1.45 hours and 
42.98±7.86 hours, respectively. The results suggested that there is no significant difference in 
specific growth rate when cells are grown on Synthemax and Matrigel surfaces. However, we 
observed that the colonies on Matrigel are bigger than on Synthemax. This was verified with 
immunofluorescence staining results described in Fig. 11 &12.  
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A 
 
B       
  
 Figure 2. (A) Growth curve of iPS cells on Synthemax and Matrigel-coated plates. (B) 
Estimation of the specific growth rate µ. Three independent experiments were conducted to 
calculate the slope µ. 
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In another experiment, we tested cell proliferation capacity on Synthemax surface.  As shown in 
Fig. 3, after culture cells on the Synthemax for more than three days, cells reached exponential 
proliferation phase with approximately 14 million cells at day 6 in a well of six-well plate. No 
differentiated cell colonies were found. It should be pointed out that cells expanded on Matrigel-
coated surface have to be subcultured on day 3~4 after plating, as relative larger colonies formed 
on the Matrigel coated surface on day 3~4 and colony-colony merge should be avoided in order 
to prevent cells from spontaneous differentiation. While cell colonies are smaller on Synthemax 
surface, which allows expansion of iPS cells for longer time before subculture. For this reason, 
we were only able to examine Matrigel-coated surface culture by 4 days of culture. The result 
obtained from Fig. 3 suggests that the productivity of iPS cell expansion is actually much higher 
than that on Matrigel-coated surface.  
 
       Figure 3. Capability of iPS cell growth on synthetic peptide surface.  
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Furthermore, in order to characterize how many passages can the synthetic peptide surface 
support iPS cell self-renewal under undifferentiated state, we detected the expression of 
pluripotency markers after 10 consecutive passages. High expression of stem cell specific 
markers OCT4 and SSEA4 could be detected after 10 consecutive passages (Fig.4), suggesting 
the cells maintained in undifferentiated state during passages. However, after 13 passages, some 
spontaneous differentiation of iPS cells was observed (Fig.5). From these, we could see 
Synthemax plate could maintain iPS cells in undifferentiated state over multiple passages.  
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  OCT4      SSEA-4        
   
 
  DAPI       DAPI                                        
 
 
Merge        Merge  
 
            
 
 
Figure 4. Fluorescence microscopy images of anti-OCT4 and anti-SSEA4 labeled iPS cells.  
IMR90 were maintained in undifferentiated state on Synthemax surface for 10 passages. Scale 
bar: 100 µm. Mouse anti-human OCT4 (1:100) and mouse anti-human SSEA4 (1:100) were used 
as primary antibodies.   Goat anti-mouse Alexa Fluro 488 IgG1 (1:200) and goat anti-mouse 
Alexa (Alexa Fluro 488 IgG3 (1:200) were used as secondary antibodies. 
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Figure 5. Distinct differentiated colonies grown on Synthemax plate after 13 passages under 
bright field. Scale bar: 50 µm. 
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3.2 Differentiation on Synthemax plate 
We next investigated whether iPS cells retain their ability to differentiate into a specific lineage 
such as a DE (Definitive endoderm) lineage. The differentiation of DE lineage is the most critical 
first step in hESC pancreatic differentiation (53). Thus, demonstration of iPSC directed DE 
differentiation on peptide surface could help develop a xeno-free differentiation system to 
generate transplantable -cells from iPS cells for diabetes therapy. Synthemax plate has been 
proved to allow differentiation of human embryonic stem cells into three germ layers (45). Here, 
we examined DE differentiation of iPS cells on the Synthemax surface as we mentioned in the 
Introduction that hES cells and iPS cells are identical on many aspects but not the same. As 
shown in Fig. 6A, the DE morphology was observed after day 5 post induction of the 
differentiation. DE marker genes, Sox17 and Foxa2 in cells differentiated on both synthetic 
peptide- and Matrigel-coated surfaces after 6 days’ differentiation were analyzed by Taqman 
qRT-PCR analysis. No expression of Foxa2 and Sox 17 could be detected in undifferentiated 
IMR90 cells on both plates (Fig. 6B & C). Both Foxa2 and Sox 17 expressed at similar levels 
and no significant difference could be observed between the differentiations on the two types of 
surfaces. This experimental result indicates that Synthemax surface is as good as Matrigel coated 
surface for induced differentiation of iPS cells into DE lineage. Further confirmation by 
immunofluorescence (Fig. 6D) shows the expression of FOXA2 and SOX17 in differentiated iPS 
cells on Sythemax. Our results indicate that the Synthemax Surface provides the appropriate 
niche environment that supports both the expansion and the directed differentiation of hiPSCs.  
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(A)           10×                                             20×                                              40× 
   
 
                    
 
(D)          FOXA2                           SOX 17                     DAPI                            Merge 
 
        
Figure 6. Definitive endoderm (DE) marker gene and protein expression in IMR90 cells 
differentiated on MG and SM. (A) Morphology of DE after 6 days of differentiation. (B) Foxa2, 
and (C) Sox17 mRNA expression detected by qRT-PCR. Data were presented as mean ±SD. (D) 
Immunofluorescence detection of DE marker. Mouse monoclonal anti-human SOX17 (1:50) and 
goat anti-mouse IgG FITC (1:100) were used as primary and secondary antibodies for SOX17. 
Rabbit monoclonal anti-human FOXA2 (1:1000) and donkey anti-rabbit IgG TRITC (1:100) 
were used as primary and secondary antibodies for FOXA2. 
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3.3 Functional role of integrins in iPS cell attachment 
Synthemax Surface is made of the VN-PAS surface as mentioned in the Introduction. It is 
reported that αVβ5 integrin mediated adhesion to vitronectin (VN), so we conducted integrin 
inhibition assay by blocking various integrins with anti-integrin antibodies before seeding the 
cells to confirm αVβ5 mediated adhesion on Synthemax plate. Seeding cells on Matrigel coated 
plates was used as control. As a result, blocking of integrin αVβ5 shows 93% inhibition of the 
attachment on the Synthemax plate (Fig. 7B), but on Matrigel coated plates no significant 
reduction of attachment could be detected. In addition, the blocking of integrins α5, α6, and β1 
only reduced the cell adhesion to the Synthemax plate by 20, 6, and 11%, respectively. The four 
integrins antibodies together nearly completely abolished the attachment of iPS cells to the 
Synthemax Surface. According to the mechanism study on the cell-matrix interaction shown in 
Fig. 7B, only one integrin is available for cell adhesion and spreading if an iPS cell interacts with 
Synthemax surface. This is because the synthetic peptide surface was made by single peptide 
sequence which was derived from vitronectin. Therefore, only integrin V5 expressed from a 
cell can bind to the peptide sequence. These results are consistent with our hypothesis that 
recognition of recombinant vitronectin protein by integrin αVβ5. By contrast, the cell seeded on 
Matrigel coated plates has much less affection by integrin blocking. Among the integrins α5, α6, 
β1 and αVβ5, integrin β1 blocking has the biggest reduction which is about 40%, meaning the role 
of β1 is more important for the attachment to Matrigel. This result is consistent with the report 
that integrin β1 is required for hiPSCs adhesion and proliferation on Matrigel-coated surfaces 
(47). The combination of antibodies against integrins α5, α6, β1 and αVβ5 resulted in a 62% 
reduction of cell adhesion to the Matrigel surface. These results suggest that multiple integrins 
are involved in mediating hiPSCs adhesion to the Matrigel surface.  
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(A)              No Ab                                           α5                                                 β1 
             
            
                 α6                                                   αV β5                                             4Ab 
              
(B) 
       
 
Figure 7. The role of integrins in promoting iPS cell adhesion to MG and SM substrates. (A) 
Micrographic images of cell attachment on SM surface without and with integrin antibodies 
blocking. Scale bar: 50 mm. (B) Relative iPSC attachment on MG and SM. Data are presented as 
the mean ± SD (n=14). *: p=0.037; **: p=0.0059; ***: p<0.0001. Symbols: Ab, antibody; MG, 
Matrigel surface; SM, Synthemax surface. Dilution of antibodies: 1:40 
 
  * 
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* 
*** 
*** 
 *** 
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3.4 Wnt pathway 
As described in the Introduction, Wnt pathway plays important roles in hES/iPS cell expansion 
and differentiation. In order to investigate whether or not this important signaling pathway was 
indeed affected by the substrates of surface matrix, we detected the nuclear translocation of β-
catenin in iPSCs grown on SM surface and compared to MG-coated surface. Proteins in the 
cytoplasm and in the nucleus were extracted separately. β-actin was used as an internal control 
for the western blot assay. As revealed in Fig 8, less β-catenin was translocated from cytoplasm 
to nucleus when cells were grown on SM compared with that on MG. The translocation of less β-
catenin to the nucleus suggested less activation of β-catenin-mediated Wnt signaling pathway in 
iPS cells grown on SM. The experimental results indicated that the lack of multiple integrins for 
iPSCs attachment and proliferation may lead to the down-regulation of Wnt signaling and thus 
support iPSCs proliferation in limited period of time as discussed above shown in Fig. 3, 4, and 
5. 
             Cytoplasm         Nuclear 
          SM           MG        SM            MG               
 
Figure 8. Cytoplasm and nuclear β-catenin expression in iPSCs grown on Matrigel (MG) and 
Synthemax (SM) surfaces. Cytoplasm and nuclear proteins were extracted separately for Western 
blot analysis. Results shown are western blotting analysis from two independent experiments. 
Antibodies: Rabbit anti-human β-catenin (1:2000), anti-rabbit IgG HRP (1:1000).  
 
 
β-Catenin 
 
β-actin 
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3.5 Organization of the cytoskeleton structures 
Cytoskeleton plays an important role in integrin related signaling transduction pathways (54, 55). 
The cytoplasmic domains of integrins bind to the cytoskeleton through adapter proteins like 
vinculin, α-actinin, and phosphorylated-focal adhesion kinase (p-FAK). In order to investigate 
how the substrate affects the organization of the cytoskeleton structures, we examined the 
expression of cytoskeleton related proteins such as actin filaments (F-actin) and vinculin during 
iPS cell proliferation on the Synthemax substrate and compared to the Matrigel-coated surface. 
Due to phalloidin binds specifically at the interface between F-actin subunits we investigated F- 
actin polymerization in iPS cells grown on the Synthemax substrate immune-stained with 
phalloidin at 48 hour after culture. As shown in Fig. 9, the actin filament network of cells on 
Synthemax surface is much different from that on Matrigel–coated surface. Cells grown on 
synthetic peptide surface showed the accumulation of denser and broader actin filaments 
between the cell-cell interfaces. Vinculin is another cytoskeletal protein that is involved in 
linkage of the cytoplasm to the focal adhesions. Expression of vinculin on both types of 
substrates was shown in the Fig.10A & B.  Western blot analysis revealed low level of vinculin 
expression in cells grown on Synthemax surface (Fig. 13A).  
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                      (A) MG (40x)                                      (B) SM (40x) 
 
DAPI            
 
F-actin               
                             
Merge         
    
 
Figure 9. Micrographic images of F-actin expression in cells grown on MG (A) and SM (B) 
surface. Scale bar: 50µm. Magnification: 40×. Antibody:  Alexa Fluor 488 phalloidin (1:40). 
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                            (A) MG (20x)                                      (B) SM (20x) 
 
 DAPI                   
 
Vinculin                                    
  
Merge              
 
    
 
 
Figure 10. Micrographic images of vinculin expression in cells grown on MG (A) and SM (B) 
surface. Scale bar: 100µm. Magnification: 20×. Rabbit anti human vinculin (1:50) and mouse 
anti-rabbit IgG –FITC (1:150) were used as primary and secondary antibodies. 
. 
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In addition, we found that there is a higher expression of zyxin protein in cells grown on 
Synthemax surface (Fig. 11).  Western blot assay revealed a significant up-regulation of zyxin in 
cells grown on the Synthemax surface (Fig. 13C).  Zyxin is a zinc-binding phosphoprotein that 
concentrates at focal adhesions and along the actin cytoskeleton. Since zyxin is directly involved 
in cell spreading and proliferation and is inversely correlated to differentiation (56), the up-
regulation may contribute to cell attachment and proliferation on the Synthemax surface.  
Moreover, we examined α-actinin expressions in cells grown on the Synthemax and Matrigel 
substrates (Fig.12) and we observed nearly similar level of α-actinin expressions on both types of 
surfaces. In the attempt of studying role of p-FAK on iPS cell-synthetic peptide surface 
interaction, significant difference of p-FAK expression were not be detected between the cells 
cultured on Matrigel and Synthemax surfaces (Fig. 14). While the mechanism of these changes 
in cell cytoskeletal proteins is unclear, it may indicate a reorganization of cellular molecules and 
focal adhesions, which facilitates the spreading and self-renewal of iPS cells on substrates, such 
as peptide surface used in this work. 
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                           DAPI                                       Zyxin                                    Merge  
(A)MG       
(B)SM       
 (C) MG        
(D)SM       
 
Figure 11.Micrographic images of Zyxin expression in cells grown on MG (A&C) and SM 
(B&D) surface. Scale bar: 100µm for A&B; 50µm for C&D. Magnification: 20× for A&B; 40× 
for C&D. Rabbit anti human zyxin (1:100) and mouse anti-rabbit IgG –FITC (1:150) were used 
as primary and secondary antibodies. 
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                        DAPI                                        α-actinin                                    Merge  
(A)MG    
(B)SM       
(C) MG      
(D)SM      
Figure 12.Micrographic images of α-actinin expression in cells grown on MG (A&C) and SM 
(B&D) surface. Scale bar: 100µm for A&B; 50µm for C&D. Magnification: 20× for A&B; 40× 
for C&D. Rabbit anti human α-actinin (1:100) was used as primary antibodies and mouse anti-
rabbit IgG –FITC (1:150) as secondary antibodies. 
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(A)        MG               SM 
 
              
 
              
                      
 
 
 
 
 
 
(B)              MG          SM 
             
 
                                          
     
 
 
 
 
(C)            MG          SM 
                    
                    
 
 
Figure 13. Cytoskeletal protein expression in iPS cells grown on Matrigel (MG) and Synthemax 
(SM) surfaces. Cells were harvested at 48 h post seeding and total proteins were extracted for 
Western blot analysis. (A-C) Vinculin, α-actinin, and zyxin expression detected by Western blot 
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analysis and relative protein expression using β-actin as a loading control respectively. Semi-
quantification of protein expression was performed by Kodak 1D gel imaging software. At least 
three independent experiments were performed and data were presented as mean ± SD. Rabbit 
anti-human vinculin (1:200), rabbit anti-human α-actinin (1:1000), rabbit anti-human zyxin 
(1:1000) were used as primary antibodies, respectively. Mouse anti-rabbit IgG HRP (1:1000) 
was used as secondary antibodies.  Bands shown are representative results from three 
experiments.  
                             
(A)MG (20x)                                      (B)SM (20x) 
 
p-FAK                              
DAPI                  
Merge             
Figure 14.Micrographic images of p-FAK expression in cells grown on MG (A) and SM (B) 
surface. Scale bar: 100µm. Magnification: 20×. Rabbit anti-human p-FAK (1:50) and mouse 
anti-rabbit IgG –FITC (1:150) antibodies were used as primary and secondary antibodies. 
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CHAPTER 4 CONCULSION AND FUTURE WORKS 
 
In this work, the attachment, proliferation, and induced differentiation of human iPS cells on 
Synthemax surface was evaluated and characterized. iPS cells colonies grown on Synthemax 
substrate exhibited less spreading and more compact morphology compared to colonies grown 
on Matrigel. We demonstrated that iPS cells retained stable proliferation and pluripotency 
marker protein expression after growing on the Synthemax substrate for ten consecutive 
passages. Further examination of cell-ECM interaction confirmed that iPS cells grown on the 
Synthemax surface primarily utilize αVβ5 integrin to mediate attachment to the substrate, since 
the Synthemax surface contains peptide sequences derived from vitronectin protein. 
Investigation of β-catenin revealed less activation of β-catenin-mediated Wnt signaling pathway 
on the Synthemax surface which might be the reason that the iPS cells colonies were more 
compact. The cytoskeleton characterization of iPS cells grown on the Synthemax surface 
revealed the formation of denser actin filaments in the cell-cell interface. The down-regulation of 
vinculin and up-regulation of zyxin expression were also observed in iPS cells grown on the 
Synthemax surface. Taken together, our experimental results suggest that Synthemax surface in 
combination with defined medium can provide a defined culture system for expansion of clinical 
grade human iPS cells for cell therapy applications. 
 
In the future, further experiments such as teratomas forming from injection of long term cultured 
iPS cells on Synthemax surface to mice can be done to further confirm Synthemax surface 
performance on the maintenance of pluripotency of iPS cells.  Importantly, as shown in Fig. 5, 
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we found that spontaneous differentiation of iPS cells became uncontrollable after more than 12 
passaging on Synthemax surface. By contrast, iPS cells can be maintained in undifferentiated 
state for more than 40 passages on Matrigel-coated surface. The experimental result is 
consistence with other group’s data (45). As Matrigel is a mixture of animal ECM proteins, it 
seems like multiple integrins expressed on the surface of iPS cell are able to bind to distinct 
ECM proteins of Matrigel, which provides to an iPS cell strong adhesion and spreading 
microenvironment. Therefore, as a future direction of developing chemically-defined synthetic 
peptide surface, multiple peptide sequences derived from various biological functional ECM 
proteins should be coated on a culture surface for long-term expansion and induced 
differentiation of hES/iPS cells. Moreover, to thoroughly investigate cellular cytoskeleton 
structure and reorganization on synthetic peptide substrate, 100x or 63x objective lens are 
essential for the study. Due to the pre-coating of the synthetic peptide on a six-well plate of 
Synthmax plate, we were unable to use a 100x objective lens to characterize the cytoskeleton 
structures. With the advent of self-coating peptide for HPSC self-renewal and induced 
differentiation, further investigation on the mechanism of cell-matrix interaction and cell fate 
affected by synthetic peptide substrates can be implemented. 
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APPENDIX 
 
5.1 Extraction of cytoplasmic and nuclear protein  
1. Harvest with trypsin-EDTA and then centrifuge at 500 × g for 5 minutes 
2. Wash cells by suspending the cell pellet with PBS.  
3. Transfer 1-10 × 106 cells to a 1.5mL microcentrifuge tube and pellet by centrifugation at 
500 × g for 2-3 minutes.  
4. Use a pipette to carefully remove and discard the supernatant, leaving the cell pellet as 
dry as possible.  
5. Add ice-cold CER I to the cell pellet (Table 1). Proceed to cytoplasmic and nuclear 
protein extraction, using the reagent volumes indicated in Table 1.  
 
6. Vortex the tube vigorously on the highest setting for 15 seconds to fully suspend the cell 
pellet. Incubate the tube on ice for 10 minutes.  
7. Add ice-cold CER II to the tube.  
8. Vortex the tube for 5 seconds on the highest setting. Incubate tube on ice for 1 minute.  
9. Vortex the tube for 5 seconds on the highest setting. Centrifuge the tube for 5 minutes at 
maximum speed in a microcentrifuge (~16,000 × g).  
10. Immediately transfer the supernatant (cytoplasmic extract) to a clean pre-chilled tube.  
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11. Suspend the insoluble (pellet) fraction produced in Step 9, which contains nuclei, in ice-
cold NER.  
12. Vortex on the highest setting for 15 seconds. Place the sample on ice and continue 
vortexing for 15 seconds every 10 minutes, for a total of 40 minutes.  
13. Centrifuge the tube at maximum speed (~16,000 × g) in a microcentrifuge for 10 minutes.  
14. Immediately transfer the supernatant (nuclear extract) fraction to a clean pre-chilled tube.  
 
5.2 Western blot 
1. Cells were cultured for 48 hours on Matrigel coated plate and Synthemax plate and 
detached by Typsin EDTA 
2. Cells were collected by centrifuged at 300 ×g for 10 min and washed by Dulbecco’s 
Phosphate buffered Saline 
3. All cells were lysed with lysis buffer by using a 1 ml syringe with 20G11/2 needle up and 
down 20 times. 
4. Cell lysates were centrifuged with 21,000 ×g at 4 oC for 15 min. 
5. Equal amount of cellular protein with 2×Laemmli loading buffer containing 5% of β-
mercaptoethanol were heated at 98°C for 5 minutes. 
6. the samples were centrifuged at 21,000 ×g for 5 min. Proteins were loaded into a 4-20% 
Mini-Protean
®
 Precast gel.   
7. Start the electrophoresis at 200 V for 35min.  
8. Pre-wet membrane in transfer buffer 10 minutes before use at room temperature.                   
9. Cut the top right corner of a membrane and label the top left corner with the blot number. 
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10.  Prepare the transfer apparatus: fill the box half full with pre-cold transfer buffer. Wet 
sponges and filter paper in transfer buffer.  
11. Carefully transfer the gel to the filter paper, such that the top right corner is on the right 
and faces away from the hinge. 
12. Transfer the membrane on top of the gel to match the orientation of the gel (nicked corner 
of gel to nicked corner of membrane). This ensures transfer of protein from left to right 
on the membrane, with marker on the left and samples numbering up. 
13. Ensure that the membrane and gel remain wet, and remove any bubbles in between them. 
Complete the transfer sandwich with filter paper and sponge, then clamp the tray closed. 
Close the transfer box, place it in a box filled with an ice. 
14. Transfer 1 hr at 100V. 
15. Perform blocking with PBST/5% non-fat dry milk and incubate for 2h, shaking at room 
temperature. 
16. Incubate with primary antibody  overnight 
17. . Wash the membrane 3 times with 1×PBST, 5 min each time 
18.  Incubate the membrane scond Antibody Peroxidase Conjugated (1:2000 in PBST/5% 
non-fat dry milk, v/v) for 1 hour  
19. Wash the cells 3 times with PBST, 5 min each. 
20. Mix the two substrate components at a 1:1 ratio to prepare the substrate Working Solution 
and incubate membrane 1 minute in the prepared Super Signal West Substrate Working 
Solution.  
21. Analyze the membrane and take images. 
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5.3 Immunofluorescent staining 
1. Rinse cells briefly twice in 0.5ml/well ice-cold PBS w/o Ca2+/Mg2+ at room temperature. 
2. Fix the samples in freshly made 0.5ml/well 4% paraformaldehyde in PBS pH 7.4 for 15 
min at room temperature with shaking. 
3. Wash the samples three times with 0.5ml/well ice-cold PBS.     
Note: The cells can be stored in 0.02% (w/v) sodium azide in PBS at 4°C for several 
days. 
4. Incubate the samples for 10 min with 0.5ml/well PBS w/o Ca2+/Mg2+ containing 0.5% 
Triton X-100 (in room temperature) with shaking.   
5. Wash cells in 0.5ml/well PBS three times, each for 5 min with shaking.  
6. Block: incubate cells with 0.5ml/well blocking buffer (5% sheep serum, 5% donkey 
serum, 0.05% Tween-20, 0.1% Triton X-100 in PBS) for 1 hour to block nonspecific 
binding of the antibodies (10% serum from the species that the secondary antibody was 
raised in) with shaking. 
7. Incubate cells in 150µl/well mixture of two primary antibodies in blocking buffer 
overnight at 4
o
C with shaking. 
8. Decant the mixture solution and wash the cells three times in 0.5ml/well wash buffer, 
each for 5 min with shaking.  
9. Dilute the fluorophore-conjugated secondary antibody/antibodies, away from light, in 
blocking buffer. Be sure that the correct isotype-specific secondary antibody for each 
primary antibody is used. 
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10. Incubate cells with 150µl/well mixture of two secondary antibodies which are raised in 
different species with two different fluorochromes (FITC-conjugated sheep against 
mouse and TRITC-conjugated donkey against rabbit) in blocking buffer for 1 hr at room 
temperature in dark with shaking. 
11. Decant the mixture of the secondary antibody solution and wash three times with PBS 
each for 5 min in dark with shaking. 
12. 4 drops of VECTASHIELD Mounting Medium with DAPI were added to each well and 
incubate for 1 minute. 
13. Visualize the cells using a fluorescence microscope equipped with the appropriate filters 
for different dyes and take images. 
 
5.4 Integrin blocking assay 
1. Detach IMR 90 cells by dispase and collect them in the 1.5 mL tube.  
2. Wash the cells by CMRL-BSA medium. 
3. Count cell numbers and add 70,000 cells in each tube with 1 ml CMRL-BSA medium.  
4. Add 10 µl integrin antibodies to each tube.  
5. Seeding on the plates and incubate at 37 oC in CO2 incubator. After incubation until the 
cells attach to the plates. 
6. Wash cells by CMRL-BSA medium for 3 times  
7. Fix by 0.5 ml/well100% ethanol for 5 minutes. 
8. Stain the cells by 0.5 ml/well 0.4% crystal violet in methanol for 5 minutes  
9. Wash the wells by dd H2O twice.  
10. Take Images count the colony numbers.   
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5.5 Purification of total RNA from animal cells using spin technology 
1. Carefully remove all medium by aspiration and wash twice by DPBS. 
2. Cells lysed directly by adding 600 µL Buffer RLT. 
3. Use pipet to mix and detach the cells and transfer to a new tube. 
4. Pass the lysate at least 5 times through a blunt 20G11/2 needle fitted to an RNase-free 
syringe. 
5. Add 1 volume of 70% ethanol to the homogenized lysate, and mix well by pipetting. 
6. Transfer up to 700 μl of the sample, including any precipitate that may have formed, to 
an RNeasy spin column placed in a 2 ml collection tube (supplied). Close the lid gently, 
and centrifuge for 15 s at ≥8000 x g (10,000 rpm). Discard the flow-through. 
7. Add 700 μl Buffer RW1 to the RNeasy spin column. Close the lid gently, and centrifuge 
for 15 s at ≥8000 x g (10,000 rpm) to wash the spin column membrane. Discard the flow-
through 
8. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and centrifuge 
for 15 s at ≥8000 x g (10,000 rpm) to wash the spin column membrane. Discard the flow-
through 
9. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and centrifuge 
for 2 min at ≥8000 x g (10,000 rpm) to wash the spin column membrane. 
10. Place the RNeasy spin column in a new 1.5 ml collection tube. Add 30–50 μl RNase-free 
water directly to the spin column membrane. Close the lid gently, and centrifuge for 1 
min at ≥8000 x g (10,000 rpm) to elute the RNA. 
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5.6 Quantitative real time–polymerase chain reaction  
1. Thaw 2x QuantiTect Multiplex RT-PCR NoROX Master Mix, template RNA, primer and 
probe solutions, and RNase-free water. Mix the individual solutions, and place them on 
ice. QuantiTect Multiplex RT Mix should be taken from –20 °C immediately before use, 
always kept on ice, and returned to storage at –20 °C immediately after use. 
2. Prepare a reaction mix according to Table A1 (multiplex RT-PCR using the LightCycler 
2.0)  
 
 
Table A1 Reaction setup for duplex on RT-PCR for other cyclers 
 
 
3. Mix the reaction mix thoroughly, and dispense appropriate volumes into PCR tubes, PCR 
capillaries, or the wells of a PCR plate. 
4. Add template RNA to the individual PCR tubes, capillaries, or wells. 
5. Program the real-time cycler according to Table A2. 
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6. Place the PCR tubes, plates, or capillaries in the real-time cycler, and start the cycling 
program. 
7. Perform data analysis. 
 
Table A2 PCR cycling conditions 
Temperature Time Cycle step 
50 
°
C 20 minutes 1cycle 
95 °C 15  minutes 1cycle 
94 °C 
60 °C 
45 seconds 
45 seconds 
 
40 cycles 
 
 
 
 
 
